Clinical trial · Observational
An Ophthalmic Safety Study in Patients With Breast Cancer
A Multicentre Study Assessing Ophthalmic Safety in Patients With Breast Cancer
NCT06767462CI-TRIAL-00114868active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To assess ophthalmic health in parallel cohorts of patients with breast cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ophthalmic Safety in Patients With Breast Cancer | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Cohort 1 from Qualifying Study
- label
- Cohort 2 from Qualifying Study
Primary outcomes (4)
- measure
- Visual Acuity Testing (Snellen units)
- timeFrame
- Ophthalmic review by central reader until 28 days after End of Study visit.
- description
- To detect potential impairment in central vision in patients with breast cancer.
- measure
- Slit Lamp examination (normal/abnormal)
- timeFrame
- Ophthalmic review by local ophthalmologist until 28 days after End of Study visit.
- description
- To detect any corneal changes or lens changes (eg, cataracts) that could impact high and low contrast acuity/visual field in patients with breast cancer.
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 130 Years
Show eligibility criteria text
Inclusion Criteria: 1. Signed informed consent in the qualifying study. 2. Signed informed consent in the ophthalmic study prior to any ophthalmic study specific assessments and procedures. 3. Completed the baseline ophthalmic examination for this study before the first dose in the qualifying study. 4. Meets all the eligibility criteria in the qualifying study Exclusion Criteria: 1. Patients not randomized and not receiving study assigned treatment in a qualifying study. 2. Patients with contraindications to any ophthalmic procedure required by the study or sensitivity/allergy to pupil dilating agents. 3. Judgement by the investigator that the patient should not participate in the ophthalmic study if the patient is unlikely to comply with study procedures, restrictions, and requirements
References
Publications (0)
Data not yet available
No reference posted for this study.